It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Jesse Anderson Corley net worth and biography

Jesse Corley Biography and Net Worth

Director of RxSight

Mr. Corley has served as a member of our board of directors since January 2015. Mr. Corley has also served as a board member of Neurolenses, Inc. since 2012, where he currently serves as Chairman of the Board, and has been a partner at Flying L Partners since 2016. Mr. Corley co-founded eyeonics, Inc. in 1998 and served as its Chief Executive Officer and Chairman of the Board until the company was sold to Bausch & Lomb, Inc. in February2008. Mr. Corley then served as President of the Surgical Division at Bausch & Lomb following its acquisition of eyeonics, Inc from 2008 to 2011. Mr. Corley also co-founded Chiron Vision Corp., a company focused on the development of LASIK, in 1987 and served as General Manager of the Refractive Surgery Division until December 1997. Mr. Corley received a Bachelor of Business Administration degree from Georgia Southern University.

What is Jesse Anderson Corley's net worth?: The estimated net worth of Jesse Anderson Corley is at least $21.00 million as of November 12th, 2024. Mr. Corley owns 468,571 shares of RxSight stock worth more than $20,996,667 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Corley may own. Learn More about Jesse Anderson Corley's net worth.
How do I contact Jesse Anderson Corley?: The corporate mailing address for Mr. Corley and other RxSight executives is , , . RxSight can also be reached via phone at 949-521-7830 and via email at [email protected]. Learn More on Jesse Anderson Corley's contact information.
Has Jesse Anderson Corley been buying or selling shares of RxSight?: During the last quarter, Jesse Anderson Corley has bought $504,106.07 in shares of RxSight stock. Most recently, on Tuesday, November 12th, Jesse Anderson Corley bought 11,111 shares of RxSight stock. The stock was acquired at an average cost of $45.37 per share, with a total value of $504,106.07. Following the completion of the transaction, the director now directly owns 468,571 shares of the company's stock, valued at $21,259,066.27. Learn More on Jesse Anderson Corley's trading history.
Are insiders buying or selling shares of RxSight?: In the last year, RxSight insiders bought shares 3 times. They purchased a total of 19,111 shares worth more than $910,786.07. In the last year, insiders at the sold shares 48 times. They sold a total of 682,140 shares worth more than $29,317,810.47. The most recent insider tranaction occured on November, 18th when insider Ilya Goldshleger sold 3,100 shares worth more than $139,500.00. Insiders at RxSight own 9.4% of the company. Learn More about insider trades at RxSight.
Information on this page was last updated on 11/18/2024.

Jesse Anderson Corley Insider Trading History at RxSight

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/12/2024	Buy	11,111	$45.37	$504,106.07	468,571
12/14/2023	Sell	12,000	$40.12	$481,440.00	13,625
11/17/2021	Buy	8,150	$12.48	$101,712.00

Jesse Anderson Corley Buying and Selling Activity at RxSight

RxSight Company Overview

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Today's Range

Now: $44.81

$43.98

$45.09

50 Day Range

MA: $49.78

$44.16

$56.14

2 Week Range

Now: $44.81

$27.51

$66.54

Volume

291,129 shs

Average Volume

690,492 shs

Market Capitalization

$1.81 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Tesla Execs are Freaking Out

From Angel Publishing | Ad

Click here to get the details.